This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Keidan, B. Articles by Katz, R. Search for Related Content Social Bookmarking                         What's this?

Plasma lipids and antidiabetic agents: a brief overview

Judith Hsia

Richard Katz

Department of Medicine, Division of Cardiology, The George Washington University Medical Center, 2150 Pennsylvania Ave NW, Washington, DC 20037, USA, domrxk{at}gwumc.edu

Key Words: hyperlipidaemia • sulphonylureas • biguanides • insulin • thiazolidinediones.

References

• American Diabetes Association. Position statement: Management of dyslipidemia in adults with diabetes. Diabetes Care 2001;24(suppl 1): 1-8.[Free Full Text]
• Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP). JAMA 2001;285:486-96.
• Haffner SM, Lehto S., Rönnemaa T. et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.[Abstract/Free Full Text]
• American Diabetes Association. Position statement: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2001;24 (suppl 1):1-10.[Free Full Text]
• Herman WH, Alexander CM, Cook JR et al. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes: Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care 1999;22:1171-8.[Abstract/Free Full Text]
• Abhimanyu G. Dyslipoproteinemia and diabetes. Endocrinol Metab Clin 1998;27:614-25.
• Caixas A., Ordonez-Llanos J., de Leiva A. et al. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 1997;6:1207-13.
• Edleman S., Henry R. Insulin therapy for normalizing glycosylated hemoglobin in type II diabetes. Application, benefits, and risks. Diabetes Rev 1995;3:312-24.
• Simonson DC, Kourides IA, Feinglos M. et al. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM: Results of two multicenter, randomized, placebo controlled clinical trials. Diabetes Care 1997;20:597-606.[Abstract]
• DeFronzo RA Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303.[Abstract/Free Full Text]
• Panahloo A. Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetics. Metabolism 1998;47:637-43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Matsumoto K., Miyake S., Yano M. et al. Increase of lipoprotein (a) with troglitazone. The Lancet 1997;350:1748-9.
• Billingham MS, Milles JJ, Bailey CJ et al. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin. Metabolism 1989;38:850-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mughal MA, Jan M., Maheri WM et al. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control. J Pakistan Med Assoc 2000;50:381-6.[Medline] [Order article via Infotrieve]
• Robinson AC, Burke J., Robinson S. et al. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care 1998;21:701-5.[Abstract]
• Fanghanel G., Sanchez-Reyes L., Trujillo C. et al. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas. Diabetes Care 1996;19:1185-9.[Abstract]
• Kiayias JA, Vlachou ED, Papadodima EL Metformin and lipoprotein(a) levels. Diabetes Care 1999;22:859.[Web of Science][Medline] [Order article via Infotrieve]
• Bell D., Ovalle F. Metformin lowers lipoprotein(a) level. Diabetes Care 1998;21:2028.[Medline] [Order article via Infotrieve]
• Bell PM, Hadden DR Current therapies for diabetes-metformin. Endocrinol Metab Clin 1997;26:523-34.[CrossRef]
• Henry R., Mudalair S. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers. Annu Rev Med 2001;52:239-57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Parulkar AA, Pendergrass ML, Granda-Ayala R. et al. Non hypoglycemic effects of thiazolidinediones. Ann Intern Med 2001;134:61-71.[Abstract/Free Full Text]
• Gavin JR III. Type 2 Diabetes: New drugs-optimal treatment strategies. Consultant 2001;4:581-9.
• Winkler K., Friedrich I., Nauck M. et al. Pioglitazone reduces dense LDLparticles in patients with type-2 diabetes. Diabetes 2001;50(suppl 2):A147.
• Tack CS, Smits P., Demacker PN et al. Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects. Diabetes Care 1998;21:796-9.[Abstract]
• Brunzell J., Cohen BR, Kreider M. et al. Rosiglitazone favorably affects LDL-C and HDL-C heterogeneity in type 2 diabetes. Diabetes 2001;50(suppl 2):A141.
• Nagai Y., Abe T., Normura G. Does pioglitazone, like troglitazone, increase lipoprotein(a) levels in diabetic patients? Diabetes Care 2001;24:408-9.[Free Full Text]
• Ovalle F., Bell D. Differing effects of thiazolidinediones on HDL subfractions and LP(a). Diabetes 2001;50(suppl 2):A461-2.
• Reaven GM, Lardinois CK, Greenfield MS et al. Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas. Diabetes Care 1990;13(suppl 3):32-6.[Web of Science][Medline] [Order article via Infotrieve]
• Marbury T., Huang WC, Strange P. et al. Repaglinide versus glyburide: a one-year comparison trial. Diab Res Clin Pract 1999;43:155-66.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dunn C., Faulds D. Nateglinide. Drugs 2000;60:607-15.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Caixas A., Perez A., Ordonez-Llanos J. et al. Lack of change of lipoprotein(a) levels by optimization of glycemic control with insulin therapy in NIDDM. Diabetes Care 1997;20:1459-61.[Abstract]
• Wolffenbuttel BH, Sels JJ, Rondas-Colbers G. et al. Comparison of different insulin regimens in elderly patients with NIDDM. Diabetes Care 1996;19:1326-32.[Abstract]
• Rivellese AA, Patti L., Romano G. et al. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients. J Clin Endocrinol Metab 2000;85:4188-92.[Abstract/Free Full Text]
• Karlander SG, Gutniak MK, Efendic S. Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failure. Diabetes Care 1991;14:963-7.[Abstract]
• Einhorn D., Rendell M., Egan JW et al. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. Clinical Therapeutics 2000;22:1395-409.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 1, 40-43 (2002)
DOI: 10.1177/14746514020020011801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Gadsby Review: Diabetic dyslipidaemia -- the case for using statins The British Journal of Diabetes & Vascular Disease, November 1, 2003; 3(6): 402 - 407. [Abstract] [PDF]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Keidan, B. Articles by Katz, R. Search for Related Content Social Bookmarking                         What's this?